Obesity and colorectal cancer risk in women

被引:132
作者
Terry, PD
Miller, AB
Rohan, TE
机构
[1] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10461 USA
[2] Deutsch Krebsforschungszentrum, Div Clin Epidemiol, D-6900 Heidelberg, Germany
关键词
D O I
10.1136/gut.51.2.191
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Several large studies of obesity and colorectal cancer risk have found no association among women but a reasonably consistent positive association among men. In women, a positive association that is stronger among, or limited to, those who are premenopausal has been suggested by studies that stratified analyses by age, although no previous study has examined the association by menopausal status. Methods: We used proportional hazards analyses to estimate hazard ratios relating obesity to colorectal cancer risk among 89 835 women aged 40-59 years at recruitment into the Canadian National Breast Screening Study, a multicentre randomised controlled trial of mammography screening for breast cancer. During an average 10.6 years of follow up (936 433 person years), a total of 527 women were diagnosed with incident colorectal cancer (363 colon and 164 rectal). Results: We found that obesity (body mass index greater than or equal to30 kg/m(2)) was associated with an approximately twofold increased risk of colorectal cancer among women who were premenopausal at baseline (hazard ratio 1.88, 95% confidence interval 1.24-2.86). There was no association among postmenopausal women (p for interaction=0.01), and there was only a weak positive association in the entire cohort. Conclusions: Our data suggest that obesity is associated with a twofold increased risk of colorectal cancer in premenopausal women but is not associated with altered risk in postmenopausal women. Effect modification by menopausal status may better explain the inconsistent or weak findings in previous studies than the presumed lack of an association among women.
引用
收藏
页码:191 / 194
页数:4
相关论文
共 38 条
[1]  
[Anonymous], 1997, USITC PUBL, VWHO/NUT/NCD/98. 1
[2]  
[Anonymous], 1997, FOOD NUTR PREV CANC
[3]  
Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S
[4]   ENDOGENOUS HORMONES AND BREAST-CANCER RISK [J].
BERNSTEIN, L ;
ROSS, RK .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :48-65
[5]  
Bruce WR, 2000, CANCER EPIDEM BIOMAR, V9, P1271
[6]   Estrogen replacement therapy and colon cancer: A clinical review [J].
Crandall, CJ .
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 1999, 8 (09) :1155-1166
[7]  
Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345
[8]   Postmenopausal hormone use and risk for colorectal cancer and adenoma [J].
Grodstein, F ;
Martinez, ME ;
Platz, EA ;
Giovannucci, E ;
Colditz, GA ;
Kautzky, M ;
Fuchs, C ;
Stampfer, MJ .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (09) :705-+
[9]   Hormone replacement therapy, reproductive history, and colon cancer: A multicenter, case-control study in the United States [J].
Kampman, E ;
Potter, JD ;
Slattery, ML ;
Caan, BJ ;
Edwards, S .
CANCER CAUSES & CONTROL, 1997, 8 (02) :146-158
[10]  
KUSKOWSKAWOLK A, 1989, INT J OBESITY, V13, P441